KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Receivables - Net (2017 - 2025)

Historic Receivables - Net for Elanco Animal Health (ELAN) over the last 9 years, with Q3 2025 value amounting to $894.0 million.

  • Elanco Animal Health's Receivables - Net rose 642.86% to $894.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $894.0 million, marking a year-over-year increase of 642.86%. This contributed to the annual value of $805.0 million for FY2024, which is 439.43% down from last year.
  • Elanco Animal Health's Receivables - Net amounted to $894.0 million in Q3 2025, which was up 642.86% from $989.0 million recorded in Q2 2025.
  • Elanco Animal Health's 5-year Receivables - Net high stood at $1.1 billion for Q2 2021, and its period low was $797.0 million during Q4 2022.
  • Over the past 5 years, Elanco Animal Health's median Receivables - Net value was $924.0 million (recorded in 2021), while the average stood at $927.9 million.
  • Its Receivables - Net has fluctuated over the past 5 years, first surged by 9617.58% in 2021, then plummeted by 1415.18% in 2022.
  • Over the past 5 years, Elanco Animal Health's Receivables - Net (Quarter) stood at $833.0 million in 2021, then dropped by 4.32% to $797.0 million in 2022, then increased by 5.65% to $842.0 million in 2023, then dropped by 4.39% to $805.0 million in 2024, then rose by 11.06% to $894.0 million in 2025.
  • Its last three reported values are $894.0 million in Q3 2025, $989.0 million for Q2 2025, and $970.0 million during Q1 2025.